Team:UCL/Science/Experiment
From 2014.igem.org
Line 262: | Line 262: | ||
<!-- This is the main text. Anything in a <p>TEXT</p> is a paragraph and will be spaced appropriately--> | <!-- This is the main text. Anything in a <p>TEXT</p> is a paragraph and will be spaced appropriately--> | ||
<p>We decided to assemble both BsDyP and ispB in a LacI cassette, inducible by IPTG. | <p>We decided to assemble both BsDyP and ispB in a LacI cassette, inducible by IPTG. | ||
- | Issues with inconclusive antibiotic effectivity led to major delays in construction of these composite parts. We first had to prove our antibiotics were functioning properly before making progress on our project.</p><br> | + | Issues with inconclusive antibiotic effectivity led to major delays in construction of these composite parts. We first had to prove our antibiotics were functioning properly before making progress on our project.</p><br/> |
<p>We confirmed the construction of our BsDyP and ispB cassettes using analytical gel digest cutting at sites E and P.</p> | <p>We confirmed the construction of our BsDyP and ispB cassettes using analytical gel digest cutting at sites E and P.</p> | ||
</div> | </div> |
Revision as of 22:06, 17 October 2014
Stage 01: Extraction of useful BioBrick plasmids from iGEM 2014 Distribution Kit
We began our project by identifying a range of BioBrick parts present in the iGEM 2014 distribution kit which we required as part of our cloning strategy. These parts primarily consisted of both constituitive and inducible promoter systems with ribosome binding sites which we could then use in conjunction with our azo-reductase BioBricks to assemble a functional azo dye degrading gene. We also decided that we would use the Red Florescent Protein expressing BioBrick as a control for any further transformation experiments. As the level of DNA present within each plate of the distribution kit is insufficient to perform digest and ligation reactions on it was necessary to transform each of these plasmids into our NEB5alpha competent cells. After growing our transformed cells overnight we then mini-prepped each of them to obtain BioBrick plasmids at suitable concentrations for future experiments.
Registry ID | Name / Function | Antibiotic Resistance | Source | Size | |
---|---|---|---|---|---|
|
BBa_K314103 | IPTG-inducible LacI Expression Cassette | Chloramphenicol | Spring 2014 BioBrick Distribution. Plate 1, Well 4D. | 1638 bp |
|
BBa_J04450 | RFP Coding Device | Chloramphenicol | Spring 2014 BioBrick Distribution. Plate 4, Well 4B. | 1069 bp |
|
BBa_R0010 | IPTG-inducible LacI Promoter | Chloramphenicol | Spring 2014 BioBrick Distribution. Plate 3, Well 4G. | 200 bp |
|
BBa_B0034 | Ribosomal Binding Site (RBS) | Chloramphenicol | Spring 2014 BioBrick Distribution. Plate 4, Well 1N. | 12 bp |
|
BBa_K518012 | RBS + RFP + double Terminator | Chloramphenicol | Spring 2014 BioBrick Distribution. Plate 1, Well 18C. | 828 bp |
|
BBa_K206000 | pBAD Strong Promoter | Chloramphenicol | Spring 2014 BioBrick Distribution. Plate 3, Well 14A. | 130 bp |
|
BBa_R0011 | LacI-Regulated, Lambda pL Hybrid Promoter | Chloramphenicol | Spring 2014 BioBrick Distribution. Plate 2, Well 6D. | 55 bp |
|
BBa_B0012 | Transcription Terminator for E. coli RNA Polymerase | Chloramphenicol | Spring 2014 BioBrick Distribution. Plate 2, Well 2B. | 41 bp |
Stage 02: Identification of useful genes for making new BioBricks
Identifying azo dye degrading enzymes
Searching through the literature, we identified a number of bacterial species (including Bacillus subtilis and Pseudomonas sp.) that have proven to degrade azo dye compounds [1][2][3][4].
We contacted the Microbial & Enzyme Technology Lab led by Dr Lígia O. Martins at the Universidade Nova de Lisboa, who are currently researching how azo dye degrading enzymes function, and they were keen to collaborate with us on our project. They agreed to send us a set of five plasmids, each containing different genes encoding azo dye degrading enzymes from both B. subtilis and P. putida (including mutated forms found to exhibit enhanced degradation activity), for us to use in our investigations (see Table below).
Gene ID | Name / Function | Source | Size | Plasmid |
---|---|---|---|---|
pAzoR | FMN-dependent NADH-azoreductase 1 | Pseudomonas putida | 612 bp | In expression vector: pET-21a (+) (ampicillin resistant) [2] [3] , initially cloned between NdeI and BamHI restriction sites. |
p1B6 | AzoR heat-stable mutant | Pseudomonas putida | 612 bp | In expression vector: pET-21a (+) (ampicillin resistant) [2] [3] , initially cloned between NdeI and BamHI restriction sites. |
pCotA | Spore Coat Protein Laccase | Bacillus subtilis | 1542 bp | In expression vector: pET-21a (+) (ampicillin resistant (ampR)) [2] [3] , initially cloned between NheI and BamHI restriction sites. |
pBsDyP | Dye Decolourising Peroxidase BSU38260 | Bacillus subtilis | 1251 bp | In expression vector: pET-21a (+) (ampicillin resistant) [2] [3] , initially cloned between NdeI and BamHI restriction sites. |
pPpDyP | Dye Decolourising Peroxidase PP_3248 | Pseudomonas putida | 864 bp | In expression vector: pET-21a (+) (ampicillin resistant) [2] [3] , initially cloned between NdeI and BamHI restriction sites. |
Extraction of B. subtilis genomic DNA
In the meantime, Helina (in our team), was able to obtain B. subtilis and P. aeruginosa strains for us to test whether we could retrieve azo dye degrading enzymes from their genomes, specifically, the azo-reductase gene (AzoR). This would be the first step for our first azoreductase BioBrick.
We extracted the genomic DNA from B. subtilis strain using a Promega Wizard Genomic DNA extraction kit so that we could subsequently amplify the azoreducatase gene (AzoR1) and create our first azoreductase BioBrick. After completing the genomic DNA extracton we ran a gel to show that we had successfully extracted the B. subtilis genomic DNA.
Stage 03: Transforming E. coli with azo-dye degrading plasmids from Lisbon
Transforming E. coli with azo-dye degrading plasmids
The five azo dye degrading enzymes from Lisbon arrived as the respective genes in pET-21a (+) ampicillin resistant (ampR) expression vectors/plasmids (size: 5443 bp)[1][2]. The DNA concentrations of these plasmids, however, were insufficient to perform PCR amplification, therefore we transformed each into our own E. coli competent cells (grown from NEB DH5α derivatives). After growing the cells overnight, we made bacterial glycerol stocks and miniprepped the cells to obtain plasmids at sufficient concentrations for further work.
Diagnostic digest of azo-dye degrading plasmids
A diagnostic digest was performed to ascertain that these pET-21a (+) plasmids contained the gene we expected. As each plasmid possessed EcoRI and XbaI restriction sites close to the genes of interest, we performed double-digests using these recognition enzymes and predicted the digest fragments. The digestion products were visualised using gel electrophoresis (see image right).
Stage 04: Creation of azo-reductase BioBrick parts from plasmids
After isolating our genes of interest we attempted to use PCR as a method of prefix and suffix generation to fit the BioBrick standard assembly.
Achieving a successful PCR proved difficult, this may have been due to poor reagent quality. We repeated the PCR using Taq, phusion and Pfu polymerases. We took an alternative route successfully used directionless ligation to generate the prefix and suffix for 1B6. Taq polymerase eventually gave us a successful generation of prefix and suffix for BsDyP, AzoR and ispB. Unfortunately, due to time constraints we were unable to implement site directed mutagenesis on 1B6 required to remove two illegal PstI and therefore did not submitt the part to the registry.
Diagnostic digest of azo-dye degrading plasmids
We confirmed the success of the PCR through gel visualisation, comparing PCR products with and without prefix and suffix.
Stage 05: Creation of azo-reductase BioBrick parts from plasmids
We decided to assemble both BsDyP and ispB in a LacI cassette, inducible by IPTG. Issues with inconclusive antibiotic effectivity led to major delays in construction of these composite parts. We first had to prove our antibiotics were functioning properly before making progress on our project.
We confirmed the construction of our BsDyP and ispB cassettes using analytical gel digest cutting at sites E and P.
Stage 06: Diagnostic digest of azo-reductase BioBrick parts
...
Stage 07: Assembling azo-reductase BioBrick Device(s)
...
Registry ID | Gene ID | Name / Function | Source | Size | Status | |
---|---|---|---|---|---|---|
BBa_K1336000 | AzoR | FMN-dependent NADH-azoreductase 1 | Pseudomonas putida | 612 bp | [In Progress]: primers designed | |
BBa_K1336001 | 1B6 | AzoR heat-stable mutant | Pseudomonas putida | 612 bp | [In Progress]: to remove 2 illegal PstI sites | |
BBa_K1336002 | CotA | Spore Coat Protein Laccase | Bacillus subtilis | 1542 bp | [In Progress]: primers designed | |
|
BBa_K1336003 | BsDyP | Dye Decolourising Peroxidase BSU38260 | Bacillus subtilis | 1251 bp | [New BioBrick Part]: submitted |
BBa_K1336004 | PpDyP | Dye Decolourising Peroxidase PP_3248 | Pseudomonas putida | 864 bp | [In Progress]: primers designed | |
|
BBa_K1336005 | ispB RNAi | RNAi of Octaprenyl Diphosphate Synthase fragment |
Escherichia coli, K12 strain | 562 bp | [New BioBrick Part]: submitted |
|
BBa_K1336006 | LacIEC+ispB | IPTG inducible ispB RNAi | Escherichia coli, K12 strain | 2208 bp | [New BioBrick Device]: submitted |
|
BBa_K1336007 | LacIEC+BsDyP | IPTG inducible BsDyP | Bacillus subtilis | 2895 bp | [New BioBrick Device]: submitted |
BBa_K729006 | CueO | Laccase | Escherichia coli | 1612 bp | [In Progress]: ascertaining identity | |
|
BBa_K500000 | LiP | Lignin Peroxidase | Phanerochaete chrysosporium | 1116 bp | [Improved Characterisation]: toxicity issues in gene synthesis. [In Progress]: to subclone into pSB1C3/pSB3C5. |
|
BBa_K729004 | nucB | Extracellular nuclease | Staphylococcus aureus | 561 bp | [Improved Function] |
Stage 08: Characterisation of azo-reductase BioBrick devices
...
Placeholder. Will be removed.
Protocols PCR analytical digest gel (digest ligation competent cells transformation miniprep)[Insert table of Our Genes]
...
...